BioCentury
ARTICLE | Clinical News

Abilify Maintena regulatory update

December 2, 2016 12:29 AM UTC

H. Lundbeck and Otsuka said FDA accepted for review an sNDA for once-monthly Abilify Maintena aripiprazole to treat bipolar I disorder. The PDUFA date is July 28, 2017. Abilify Maintena is approved to...